Historical insights and current perspectives on the diagnosis and management of pre-symptomatic type 1 diabetes
Simmons K, Frohnert B, O’Donnell H, et al.
Diabetes Technol Ther. Pub. online 11 Sep 2023.
Leggi
Differential evolution of diabetic ketoacidosis in adults with pre-existent versus newly diagnosed type 1 and type 2 diabetes mellitus
Ata F, Khan AA, Khamees I, et al.
BMC Endocr Disord. 2023;23(1):193.
Leggi
Empagliflozin normalizes fasting hyperglycemia and improves postprandial glucose tolerance in totally pancreatectomized patients: a randomized, double-blind, placebo-controlled crossover study
Baekdal M, Nielsen SW, Hansen CP, et al.
Diabetes Care. 2023;dc230645.
Leggi
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation
Kaptoge S, Seshasai SRK, Su L, et al.
The Lancet Diabetes and Endocrinology. Pub. online 11 Sep 2023.
Leggi
Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis
Karakasis P, Patoulias D, Pamporis K, et al.
Diabetes Obes Metab. Pub. online 5 Sep 2023.
Leggi
Expected basal insulin requirement during CSII therapy by age group, sex and BMI, based on 25,718 young people with type 1 diabetes in the DPV registry
Biester T, Eckert A, Becker M, et al.
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Comparison of glycemic risk index (GRI) with time in range for assessing glycemic quality
Kim JY, Yoo JH, Kim JH
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Sportcity Day 2023: 140 città italiane in movimento | Domenica 17 settembre – Con la collaborazione di FeSDI
Carissimi Soci, nell’ambito della Campagna #IlDiabeteUnaMalattiaMoltoComune, siamo lieti di informarvi che domenica 17 settembre si celebra la Giornata nazionale per la salute e il benessere nelle città e SportCity Day, iniziativa promossa da Health City Institute, C14+ e Fondazione SportCity con la collaborazione di FeSDI (Alleanza per il diabete AMD e SID). Il tema…
Leggi
Dapagliflozin improves erectile dysfunction in patients with type 2 diabetes mellitus: an open‐label, non‐randomized pilot study
Cannarella R, Condorelli RA, Leanza C, et al.
Diabet Med. 2023;e15217.
Leggi
Telemedicine in the treatment of gestational diabetes: an observational cohort study on pregnancy outcomes and maternal satisfaction
Montori S, Lugli F, Monesi M, et al.
Diabet Med. 2023;e15201.
Leggi